Last May I wrote about an outrageous incident I experienced watching pharmaceutical marketing executives lying to their own employees.
Today, Advertising Age reports that Merck and Schering-Plough spent $100 million advertising the cholesterol drug Vytorin for a year, despite having findings that showed the drug didn’t deliver the results promised in the ad. That’s right one whole year of lying to consumers.
Maybe it’s time to end the direct-to-consumer pharmaceutical advertising.

Cerberus announced today that former GE and Home Depot executive Bob Nardelli is taking over as CEO of 

